BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais-Rodrigues C, Seber A, Atta EH, de Oliveira JSR, Funke VAM, Loth G, Junior LGD, Paz A, Calixto RF, Gomes AA, Araujo CES, Colturato V, Simoes BP, Hamerschlak N, Flowers ME, Pasquini R, Rocha V, Bonfim C. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia. Biol Blood Marrow Transplant 2020;26:2311-7. [PMID: 32949751 DOI: 10.1016/j.bbmt.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Man Y, Lu Z, Yao X, Gong Y, Yang T, Wang Y. Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation. Front Immunol 2022;13:911174. [PMID: 35720412 DOI: 10.3389/fimmu.2022.911174] [Reference Citation Analysis]
2 Bonfim C, Nichele S, Loth G, Funke VAM, Nabhan SK, Pillonetto DV, Lima ACM, Pasquini R. Transplantation for Fanconi anaemia: lessons learned from Brazil. The Lancet Haematology 2022;9:e228-36. [DOI: 10.1016/s2352-3026(22)00032-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Hashem H, Rihani R, Shanap MA, Khattab E, Tbakhi A, Sultan I. Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies. Bone Marrow Transplant 2021. [PMID: 34839361 DOI: 10.1038/s41409-021-01536-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Luo XH, Zhu Y, Chen YT, Shui LP, Liu L. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update. Front Immunol 2021;12:732826. [PMID: 34777342 DOI: 10.3389/fimmu.2021.732826] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Xie Y, Parekh J, Tang Z, Wu D, Wu X. Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Transplant Cell Ther 2021;27:687.e1-7. [PMID: 33989833 DOI: 10.1016/j.jtct.2021.04.030] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Xu ZL, Huang XJ. Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings. Expert Rev Hematol 2021;14:449-55. [PMID: 33945370 DOI: 10.1080/17474086.2021.1923475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Scheinberg P. Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries. Br J Haematol 2021. [PMID: 33855695 DOI: 10.1111/bjh.17403] [Cited by in F6Publishing: 5] [Reference Citation Analysis]